http://groups.yahoo.com/group/aspartameNM/message/790

RTM: Moseley:
review Roberts "Aspartame Disease: An Ignored Epidemic" 2.7.2 rmforall

Subject: Review of Dr. Roberts book from Journal of Neurosurgery,
Aspartame Disease: An Ignored Epidemic
Date: Wed, 09 Jan 2002 01:24:52 -0500
From: Betty Martini <Mission-Possible-USA@...>
To: "aspartame@onelist.com" <aspartame@onelist.com>

This review is by Charles D. Moseley, M.D., Clinical Studies,
Washington, D.C.
Falls Church, Virginia

I think its an excellent review except when Dr. Moseley mentions "lack
of balance," he didn't realize that aspartame is a universal poison,
and there is no other side of it.
And as far as getting through the FDA, he likewise
didn't realize that the FDA did not say to approve it, they
first wanted the company indicted for fraud, but the U.S. Prosecutors
hired on with the defense team. Then after not approving it for 16
years, when Dr. Arthur Hull Hayes was appointed by President Reagan,
obviously to approve it,
the FDA's Board of Inquiry said it was never proven safe,
and couldn't be approved, because it had triggered brain tumors.
Dr. Hayes simply over-ruled the Board of Inquiry, and approved a drug
masquerading as an additive, that the FDA said was not safe.
Then went to work for the PR agency of the manufacturer.

I've always referred to Dr. Roberts book as a medical text, because
that's what it is. If a physician has no knowledge of aspartame,
there is no way of diagnosing the problems it causes.
With this text, all they have to do is look up the reaction.
I've also said Aspartame Disease: The Ignored Epidemic
is to the drug/toxin aspartame like the PDR is to adverse
reactions on other drugs. It's just that aspartame is so deadly, it
takes an entire medical text to give the adverse reactions instead of a
page. Now here is the review:

Aspartame Disease: An Ignored Epidemic, H. J. Roberts,
West Palm Beach, Florida: Sunshine Sentinel Press 2001,
1018 pp. illus. ISBN 1884243-177. Price $75.00

Charles Moseley, M.D.,
Clinical Studies, Washington
Falls Church, Virginia

[ http://www.thejns-net.org/
http://www.thejns-net.org/jns/issues/current/toc_fs.html
Journal of Neurosurgery
Vol. 96, January, 2002, p. 153-4

"...a psychiatrist with psychopharmacology research experience..."
Moseley, Charles, MD
Arlington, VA 703/527-9099
listed as staff at http://dominionhospital.com
Dominion Hospital mental health facility
2960 Sleepy Hollow Road
Falls Church , VA 22044
(703) 536-2000 fax (703)536-6601 ]

To read Aspartame Disease: An Ignored Epidemic is something like
reading the "Warnings and Adverse Effects" section of the
Physicians' Desk Reference, with the added impact of being told that
this information is being intentionally withheld from the consuming
public.

The result, we are told, is an epidemic as multifaceted as the many
faces of depression, both psychological and somatic. It is the somatic
which will be of most concern to the neurosurgeon,
with a broad array of neuropathological disorders
attributed directly to toxic effects on
neuronal tissues. These include
seizures, atypical peripheral neuropathies, motor neuron disease,
tremors, pseudotumor cerebri and malignant brain tumors.
This author directs attention, for instance, to several
prolactin-secreting pituitary tumors found in patients who were heavy
consumers of aspartame, correlated with the known prolactin-stimulating
effect of phenylalanine
(a direct breakdown product of aspartame in the body),
and multiple instances of pituitary tumors in exposed rats, as cited in
the Bressler Report. [http://www.dorway.com/bresslr5.html ]

The author, H. J. Roberts, M.D., an internist, is director of the Palm
Beach Institute of Medical Research and has clearly dedicated himself
to warning both professional and general readers of an
"imminent public health hazard," noting that at least 66% of adults and
40% of children in America currently consume aspartame.

The biochemistry is interesting. The primary breakdown product of
aspartame is a synthetic substance made by combing the amino acids
L-phenylalanine and L-aspartic acid with the ester of methyl alcohol
(also known as wood alcohol), which produces a
"phenylalanine-containing dipeptide."
Breakdown in the body is simply the reverse, which results in rapid
absorption into the portal circulation and
across the blood-brain barrier.

As a psychiatrist with psychopharmacology research experience,
I wonder about the effects of the dopamine precursor
L-phenylalanine on neurotransmission.
It is notable that disturbed
dopamine metabolism is attracting increasing interest
in neuropsychiatry as an important component
of numerous psychopathological conditions,
most notable affective disorders (bipolar disorder and major
depression).

Additionally, I wonder about the neurotoxic effects of wood
alcohol, noted by Dr. Herbert Posner of the National Institute of
Environmental Sciences in l975, to produce "delayed and irreversible
effects on the nervous system (of methanol) at widely varying levels of
exposure and at rather low levels."

My major criticism of this work is the absence of balance; there is
clearly another side of the argument, as attested by the fact that
aspartame won approval in a contentious Food and Drug Administration
approval process.
It is not enough to dismiss the studies supporting its safety
as "industry sponsored".
Nor is it sufficient to characterize numerous regulatory,
scientific and legal organizations' acceptance of the safety data
they received as invalid stamps of approval, because they "did not
insist upon independent confirmatory studies by corporate-neutral
investigators."

Perhaps the greatest benefit of this work for the practitioner of
medicine is to raise the index of suspicion that aspartame may be an
otherwise hidden causal agent in a wide array of neuropathological
conditions.

For the researcher, a well-designed study with the goal of determining
the answer to the threshold question:
Does aspartame consumption result in increased incidence
of neuropathological signs and symptoms? would seem
an important next step. We are, after all, talking about a substance
that is being consumed by Americans
in quantities of pounds per year per person.
Charles D. Moseley, M.D.

More information on aspartame on http://www.dorway.com
Congratulations Dr. Roberts! As many have said, one day Aspartame
Disease may become known as Roberts Disease!
http://www.aspartameispoison.com

All my best, Betty Martini http://www.dorway.com
******************************************************************

Rich Murray, MA Room For All rmforall@...
1943 Otowi Road, Santa Fe NM USA 87505 505-986-9103

http://groups.yahoo.com/group/aspartameNM/messages for 783 posts
http://groups.yahoo.com/group/aspartameNM/message/657 45K post
http://groups.yahoo.com/group/aspartameNM/message/763 30K post

http://www.dorway.com/tldaddic.html 5-page review
"Aspartame (NutraSweet) Addiction"
H.J. Roberts in "Townsend Letter", Jan 2000 HJRobertsMD@...
http://www.sunsentpress.com/ sunsentpress@...
Sunshine Sentinel Press P.O.Box 17799 West Palm Beach, FL 33416
800-814-9800 561-588-7628 561-547-8008 fax

http://groups.yahoo.com/group/aspartameNM/message/669
1038-page medical text "Aspartame Disease: An Ignored Epidemic"
published May 30 2001 $ 85.00 postpaid data from 1200 cases
available at http://www.amazon.com
over 600 references from standard medical research
http://www.aspartameispoison.com/contents.html 34 chapters

http://groups.yahoo.com/group/aspartameNM/message/652
Ann Pharmacother 2001 Jun;35(6):702-6
Relief of fibromyalgia symptoms following
discontinuation of dietary excitotoxins.
terpening@... cterpeni@...
Smith JD, Terpening CM, Schmidt SO, Gums JG.
Malcolm Randall Veterans Affairs Medical Center, Gainesville, FL, USA.
gums@... siggy@...

http://groups.yahoo.com/group/aspartameNM/message/782
RTM: Smith, Terpening, Schmidt, Gums:
full text: aspartame, MSG, fibromyalgia 1.17.2 rmforall
http://groups.yahoo.com/group/aspartameNM/message/787

http://groups.yahoo.com/group/aspartameNM/message/790
RTM: Hetle & Eltervaag:
abstract: aspartame brain damage in mice 2.5.2 rmforall

http://groups.yahoo.com/group/aspartameNM/message/752
Headache 2001 Oct;41(9):899-901
Migraine MLT-Down: An Unusual Presentation of Migraine
in Patients With Aspartame-Triggered Headaches.
[Merck 10-mg Maxalt-MLT, for migraine, has 4 mg aspartame,
while 12 oz diet soda has 200 mg.]
Newman LC, Lipton RB. RLipton@...
Headache Institute, St. Lukes-Roosevelt Hospital Center, New York
NY Department of Neurology
Albert Einstein College of Medicine, Bronx, NY
Innovative Medical Research
******************************************************************

http://aamr.allenpress.com/aamronline/?request=get-static&name=mr-info
http://web.syr.edu/~thechp/mreditor.htm
one of dozens of Consulting Editors: Charles Moseley
Steven J. Taylor, Editor, Mental Retardation
Center on Human Policy
805 South Crouse Avenue, Syracuse, NY 13244-2280.

Mental Retardation is published bi-monthly
by the American Association on Mental Retardation
444 North Capitol Street, N.W., Suite 846, Washington, DC 20001-1512.
Subscription rates: $85 for one year; $155, 2 years; $225, 3 years;
single issue, $25. For Canada, add $6; others, add $15

Mental Retardation is a journal of policy, practices, and perspectives
that provides information to mental retardation and developmental
disability professionals and families. According to the most recent
Journal Citation Reports impact factor rankings, Mental Retardation is
ranked No. 2 in "Special Education" and No. 3 in "Rehabilitation".

Mental Retardation is devoted to meeting the information needs of those
who seek effective ways to help people with mental retardation and their

families. The journal reports new teaching approaches, program
developments, administrative tools, program evaluation, service
utilization studies, community surveys, public policy issues, training
and case studies, and research that emphasizes the new application of
methods. Mental Retardation is a peer-reviewed journal whose consulting
editors represent a broad spectrum of settings: universities, research
centers, public and private residential care facilities,
and specialized community service agencies.
*********************************************************